A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.

A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.

Item
http://www.wikidata.org/entity/Q40020163
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.Biosafe nanoscale pharmaceutical adjuvant materialsCharacterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced ImmunogenicityTargeting MYC dependence in cancer by inhibiting BET bromodomainsTargeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemiaGemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin.Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques.Antibody-based therapeutics for the treatment of human B cell malignanciesTargeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells.Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies.Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes.Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists.In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis.Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models.
P2860

A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.

Item
http://www.wikidata.org/entity/Q40020163
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A novel Raji-Burkitt's lymphom ...... eted immunotherapeutic agents.
@en
type
label
A novel Raji-Burkitt's lymphom ...... eted immunotherapeutic agents.
@en
prefLabel
A novel Raji-Burkitt's lymphom ...... eted immunotherapeutic agents.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
A novel Raji-Burkitt's lymphom ...... eted immunotherapeutic agents.
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-07-1006
P407
P433
P478
P50
P577
P5875
P698
P921